← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

J

$ Value

$0

Shares

4,198

Price

$0

Filed

Mar 4

Insider

Name

Mathers Edward T

Title

CIK

0001328625

Roles

Director

Transaction Details

Transaction Date

2026-03-02

Code

J

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

9,969

Footnotes

NEA Partners 13, L.P. ("NEA Partners 13") made a pro rata distribution for no consideration of shares of Common Stock of the Issuer to its limited partners on March 2, 2026. The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 4,198 shares of Common Stock of the Issuer in the distribution by NEA Partners 13 on March 2, 2026. | The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.

Filing Info

Accession No.

0001193125-26-091684

Form Type

4

Issuer CIK

0001649904

Mathers Edward T's History

Date Ticker Type Value
2026-03-12 RYTM J $0
2026-03-10 KRRO $2.3M
2026-03-10 KRRO $2.7M
2026-03-02 RYTM J $0
2026-02-09 SGP C
2026-02-09 SGP C
2026-02-09 SGP C
2026-02-09 SGP C
2026-02-09 SGP $15.0M
2026-02-09 SGP C

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
$503K 2026-03-04
Mathers Edward T 2026-03-12
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-11
Smith Hunter C
Chief Financial Officer
$2.2M 2026-03-02
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-11
Cramer Pamela J.
Chief Human Resources Officer
2026-02-11
Shulman Joseph
Chief Technical Officer
2026-02-11
Garfield Alastair
Chief Scientific Officer
2026-02-11